Skip to main content

Upcoming Funding Opportunities

October 2024

PAR-24-209, NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)

Deadline:
  • Only accepting applications that do not propose clinical trials.
  • The total period of support is five years (up to two years intramural, plus three years extramural).

The purpose of the NHLBI Career Transition Award (K22) program is to provide highly qualified postdoctoral fellows and other doctoral-level researchers currently in training in the NHLBI Division of Intramural Research with the opportunity to transition their research programs to extramural institutions as junior investigators. To achieve these objectives, the NHLBI Career Transition Award will support two phases of research: a mentored intramural phase (up to two years) and an extramural phase (three years), for a total of five years of combined support. Transition from the intramural phase of support to the extramural phase is not automatic.

PAR-24-030, CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)

Deadline:
  • Anticipated Number of Awards: 4
  • Anticipated Amount of Funding Available: $2 million
  • Application budgets may not exceed $300,000 per year in direct costs
  • Maximum project is three years

This announcement invites applications for basic research projects on chemical warfare agents, toxic industrial chemicals, and pesticides that have primary or secondary effects on the nervous system. Chemical threats are toxic compounds that could be used in a terrorist attack or accidentally released from industrial production, storage, or shipping. Projects supported by this NOFO are expected to generate data that elucidate mechanisms of toxicity of these agents, possible new manifestations of toxic exposures, and potential new targets for therapeutic development.

November 2024

RFA-ES-24-004, Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional)

Deadline:
  • Estimated Number of Awards: 4-5
  • Anticipated Amount of Funding: $4 million
  • Application budgets are limited to $600,000 direct costs per year.
  • The maximum project period is 6 years.

The NIEHS Revolutionizing Innovative, Visionary Environmental health Research (RIVER) program is intended to provide support for outstanding investigators in the Environmental Health Sciences, giving them intellectual and administrative freedom, as well as sustained support to pursue their research in novel directions in order to achieve greater impacts.

RFA-AI-24-041, Novel Approaches for Radiation Biodosimetry and Medical Countermeasure Development (R21 Clinical Trial Not Allowed)

Deadline:
  • Estimated Number of Awards: 12-14
  • Anticipated Amount of Funding: $2 million
  • No more than $100,000 direct costs may be requested in any single year.
  • Combined budget may not exceed $200,000 in direct costs for the two-year project period

The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate and support novel ideas in radiation research, focused on medical countermeasures (MCMs), biodosimetry, and/or animal model development to diagnose, mitigate, or treat injuries sustained during a radiation mass casualty incident. These studies may involve considerable risk, but could lead to breakthroughs in a particular area, or the development of novel techniques, agents, methodologies, models, or applications that could have a beneficial impact on the radiation field.

RFA-AI-24-045, Promoting Innovative Research in Treponema pallidum Pathogenesis (R21 Clinical Trial Not Allowed)

Deadline:

The NIH recognizes that teams comprised of investigators with diverse perspectives working together and capitalizing on innovative ideas and distinct viewpoints outperform homogeneous teams. There are many benefits that flow from a scientific workforce rich with diverse perspectives, including: fostering scientific innovation, enhancing global competitiveness, contributing to robust learning environments, improving the quality of the research, advancing the likelihood that underserved populations participate in, and benefit from research, and enhancing public trust.

NSF 24-592, Ecology and Evolution of Infectious Diseases (EEID)

Deadline:
  • Estimated Number of Awards: 10
  • Anticipated Amount of Funding: $32 million

The multi-agency Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, organismal, and social drivers that influence the transmission dynamics of infectious diseases. The central theme of submitted projects must be the quantitative, mathematical, or computational understanding of pathogen transmission dynamics. The intent is discovery of principles of infectious disease (re)emergence and transmission and testing mathematical or computational models that elucidate infectious disease systems. Projects should be broad, interdisciplinary efforts that go beyond the scope of typical studies.